MedPath

A multi-center randomized controlled trial Comparing Standard Prednisolone therapy with Standard Prednisolone therapy + High-dose Mizoribine for the Treatment of early-relapsing steroid sensitive nephrotic syndrome in children (JSKDC05)

Not Applicable
Conditions
Steroid sensitive nephrotic syndrome in children
Registration Number
JPRN-UMIN000005103
Lead Sponsor
Japanese Study Group of Kidney Disease in Children
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Other renal nephrotic syndrome(persistent hematuria) (2)History of Henoch-Sch&ouml;nlein nephritis, systemic lupus erythematosus or secondary nephrotic syndrome (3)History of steroid resistant (4)History of immunosuppressants administration against nephrotic syndrome (5)Uncontrollable hypertension (6)Renal dysfunction(creatinine clearance < 90 mL/min) (7)Severe liver dysfunction (8)Patients enrolling another clinical trials at the first relapse (9)Judged inappropriate for this study by the physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath